concerta toimeainet prolongeeritult vabastav tablett
janssen-cilag farmaceutica - metüülfenidaat - toimeainet prolongeeritult vabastav tablett - 27mg 60tk
rispolept 1 mg õhukese polümeerikattega tablett
johnson & johnson uab - risperidoon - õhukese polümeerikattega tablett - 1mg 100tk; 1mg 20tk; 1mg 60tk; 1mg 500tk; 1mg 50tk; 1mg 6tk
rispolept 2 mg õhukese polümeerikattega tablett
johnson & johnson uab - risperidoon - õhukese polümeerikattega tablett - 2mg 500tk; 2mg 60tk; 2mg 100tk; 2mg 10tk; 2mg 20tk; 2mg 50tk
rispolept 4 mg õhukese polümeerikattega tablett
johnson & johnson uab - risperidoon - õhukese polümeerikattega tablett - 4mg 20tk; 4mg 10tk; 4mg 60tk; 4mg 30tk
rispolept 3 mg õhukese polümeerikattega tablett
johnson & johnson uab - risperidoon - õhukese polümeerikattega tablett - 3mg 60tk; 3mg 20tk; 3mg 50tk; 3mg 100tk
stugeron tablett
johnson & johnson uab - tsinnarisiin - tablett - 25mg 50tk
vermox 100 mg tablett
lex ano uab - mebendasool - tablett - 100mg 6tk
vermox 100 mg tablett
ideal trade links uab - mebendasool - tablett - 100mg 6tk
comirnaty
biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaktsiinid - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. kasutamist see vaktsiin peaks olema kooskõlas ametlike soovitustega.
concerta toimeainet prolongeeritult vabastav tablett
johnson & johnson uab - metüülfenidaat - toimeainet prolongeeritult vabastav tablett - 36mg 28tk; 36mg 30tk